Stock GEAN GENETIC ANALYSIS
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Genetic Analysis

Equities

GEAN

NO0010692130

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 23:00:00 07/05/2024 BST 		5-day change 1st Jan Change
0.79 NOK +41.07% Intraday chart for Genetic Analysis +29.51% -7.06%
02-29 Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
02-26 Genetic Analysis AS Announces CE-IVD Marking for its GA-map Sample Collection Kit CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Genetic Analysis AS Announces CE-IVD Marking for its GA-map Sample Collection Kit
Genetic Analysis Partners Up to Enter the Consumer Market with Ga-Map
Genetic Analysis AS Announces Resignation of Staffan Strömberg from the Board of Directors
Genetic Analysis AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Genetic Analysis AS Provides Earnings Guidance for the Year 2023, 2024, and 2025
Genetic Analysis AS Launches the GA-map® Discovery - New Microbiome Profiling Service Offering Directed to Research Customers in the Academia and Microbiome Industry
Genetic Analysis AS Announces Development Project Initiated for A New Companion Diagnostic Test
Genetic Analysis AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Genetic Analysis AS Enters an Agreement with Elta90 Group to Distribute and Launch Ga-Map[®] Technology in the Balkan Region
Genetic Analysis AS Reports Earnings Results for the First Quarter Ended March 31, 2023
Genetic Analysis AS Announces Changes in Members of Nomination Committee
Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
Genetic Analysis AS Announces Executive Changes
Genetic Analysis as Achieves Thai Fda License for Ga-Map[®] Dysbiosis Test in Thailand
Genetic Analysis as Enters an Agreement with A Major Diagnostic Company for Distribution of GA-map in Europe
Genetic Analysis AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Genetic Analysis AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Genetic Analysis and Servatus Enter Strategic Collaboration Agreement to Develop New Microbiome Diagnostostic and Therapeutic Solutions
Genetic Analysis AS and Omnigene Medical Technologies Ltd. Enter a Distribution Agreement to Launch GA-mA-map
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GEAN Stock
  4. News Genetic Analysis
  5. Other languages